FL is ranked among the top physicians in the nation based on patient reviews.
April 10, 2013 /PRNewswire-USNewswire/ -- Patients' Choice has announced that Dr.
Roselind Bardisa was one of a select few physicians honored with the prestigious 2012
Compassionate Doctor Certification.
Each year, nearly 100 million patients across the U.S. access websites like
Patients' Choice to provide feedback about experiences with their physicians.
Only those physicians with near perfect overall and bedside manner scores, as voted by their patients, are selected for the Compassionate Doctor recognition. Of the nation's 870,000 active physicians, only 3% were accorded this honor in 2012.
The Compassionate Doctor certification is part of the Patients' Choice recognition program, where patients rate and vote for their favorite doctors.
commented on the recognition: "This is quite an honor for me. I am very pleased to have been selected and grateful to my patients who went out of their way to rate me and give me positive reviews."
a short profile by and about the honoree:
Roselind H. Bardisa
is board certified in Family Medicine and Anti- Aging Medicine. She has been practicing medicine for over 15 years and specializes in preventative medicine, nutrition and fitness. Her approach to each patient includes Weight Loss, Bioidentical Hormone Replacement and performs aesthetic procedures like Botox to help her patients "Live Younger Longer". She has given numerous lectures in the field and has appeared as a medical expert on various international radio and TV shows.
For more information on this
, please visit Dr.
profile on Vitals.com
Following the publication of Dr.
selection for the
Patients' Choice Award
, American Registry seconded the honor and added Dr. Bardisa to The Registry™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor. The doctor's custom wall plaque is
For more information on Dr.
, located in
call 305-661-2002, or visit
This press release was written by American Registry, LLC with approval by and/or contributions from Dr. Bardisa and was distributed by PR Newswire, a subsidiary of UBM plc.